Found 197 articles for: "melasma"
Laser and Energy Treatments for Acne Scarring: A Review of Clinical Trials
December 2024 | Volume 23 | Issue 12 | Original Article | 1058 | Copyright © December 2024
Background: Acne scarring can have a detrimental impact on quality of life, making early and effective treatment essential. Lasers and energy-based treatment are the preferred tr...
Read MoreINDIVIDUAL ARTICLE: USCOM IV Algorithm for the Prevention and Management of Targeted Therapy-Related Cutaneous Adverse Events
December 2024 | Volume 23 | Issue 12 | Supplement Individual Articles | 436613s3 | Copyright © December 2024
Introduction: Targeted therapy has improved clinical outcomes for various types of cancer. However, their use is associated with dermatologic adverse events that impact quality o...
Read MoreTreatment of Mild to Severe Acne Vulgaris With a 650-Microsecond 1064-nm Nd:YAG Laser
November 2024 | Volume 23 | Issue 11 | Original Article | 957 | Copyright © November 2024
Background: Effective treatment of acne remains a challenge to dermatologists.Objective: To evaluate the efficacy and tolerability of a 650-microsec...
Read MoreAttitudes on, Practices, and Recommendations for Visible Light Protection Amongst Dermatology Practitioners
November 2024 | Volume 23 | Issue 11 | Original Article | 965 | Copyright © November 2024
Background: Iron oxides, antioxidants, and pigmentary titanium dioxide are sunscreen additive ingredients that enhance visible light protection, reduce associated hyperpigme...
Read MoreIsobutylamido Thiazolyl Resorcinol (Thiamidol) for Combatting Hyperpigmentation: A Systematic Review of Clinical Studies
November 2024 | Volume 23 | Issue 11 | Original Article | 986 | Copyright © November 2024
Background: Tyrosinase is the rate-limiting enzyme of melanogenesis and thus an ideal inhibitory target for treating hyperpigmentation. There are many commercially available tyro...
Read MoreA Single-Center, Open-Label, Prospective Study of a 589/1319 nm Dual Wavelength Laser for the Treatment of Facial Hyperpigmentation
November 2024 | Volume 23 | Issue 11 | Original Article | 943 | Copyright © November 2024
Background: Facial hyperpigmentation, characterized by the excessive production of melanin in the skin, is a prevalent dermatological concern affecting individuals of various eth...
Read MoreA Review of Energy-Based Device Interventions to Treat Keloid Scars
November 2024 | Volume 23 | Issue 11 | Original Article | 998 | Copyright © November 2024
Keloids are thickened raised scars that develop due to injury and grow beyond the boundaries of their original wound, mostly affecting individuals with skin of color. This review explores the use...
Read MoreINDIVIDUAL ARTICLE: Real-World Patient Cases Using Triple Lipid-Containing Cream for Cutaneous Healing Post Laser or Microneedling Radiofrequency Treatment
September 2024 | Volume 23 | Issue 9 | Supplement Individual Articles | 68821s3 | Copyright © September 2024
Lipids play an essential role in skin barrier health. With age, there is a natural reduction of physiological lipids such as fatty acids, ceramides, and cholesterol. The triple lipid restore crea...
Read MoreTreatment of Acne Vulgaris-Associated Post-Inflammatory Dyschromia With Combination of Non-Ablative Laser Therapy and Topical Antioxidants
September 2024 | Volume 23 | Issue 9 | Original Article | 769 | Copyright © September 2024
Acne can cause disfiguring sequelae, such as scarring, post-inflammatory erythema (PIE), and post-inflammatory hyperpigmentation (PIH). These post-inflammatory dyschromias pose a significant psyc...
Read MoreINDIVIDUAL ARTICLE: Skincare in Skin of Color: A Comprehensive Approach to Preprocedure, Intraprocedure, and Postprocedure
August 2024 | Volume 23 | Issue 8 | Supplement Individual Articles | 62041s5 | Copyright © August 2024
Hyperpigmentation, uneven skin tone, textural changes, and dull skin are common cosmetic concerns in skin of color. Other signs of aging, including fine lines, deeper wrinkles, and skin laxity, a...
Read MoreThe Burden of Melasma: Race, Ethnicity, and Comorbidities
August 2024 | Volume 23 | Issue 8 | Features | 691 | Copyright © August 2024
Introduction: In an effort to define the characteristics of populations affected by melasma, we utilized a large global health research network database from 108 health care orga...
Read MorePhoto Visualization of Skintone Compatibility of an SPF 35 Sunscreen
July 2024 | Volume 23 | Issue 7 | Original Article | 515 | Copyright © July 2024
Background: Visual casts and discoloration are common barriers to sunscreen use in melanin-rich populations. However, photoprotective measures are essential for individuals with ...
Read MoreRepresentation of Skin of Color in Social Media Discussions on Melasma, Keloids, and Vitiligo
July 2024 | Volume 23 | Issue 7 | Original Article | 510 | Copyright © July 2024
Background: The prevalence of social media as a source of medical information has grown substantially in recent years, especially for skin conditions disproportionately affecting...
Read MoreUpdates on the Molecular Basis of Photoaging in All Skin Types
July 2024 | Volume 23 | Issue 7 | Original Article | 504 | Copyright © July 2024
Photoaging is a complex, ongoing process that clinically manifests as cutaneous rhytides, atrophy, laxity, dyspigmentation, telangiectasias, roughness, and mottled appearance of the skin. There is an ...
Read MoreSunscreen Use for Photoprotection in Skin of Color: A Literature Review
July 2024 | Volume 23 | Issue 7 | Features | 575 | Copyright © July 2024
Background: To understand the prevalence and types of publications addressing darker skin types within the existing evidence base for sunscreen use.Evi...
Read MoreHyperpigmented Macules and Patches on the Face: Exogenous Ochronosis or Lichen Planus Pigmentosus?
July 2024 | Volume 23 | Issue 7 | Case Reports | 567 | Copyright © July 2024
We present a case of a patient with a 10-year history of blue-black macules and patches on the face and an associated history of skin-lightening cream usage. The skin lightening cream contained h...
Read MoreEfficacy, Safety, Satisfaction, Adherence to Treatment With Nano-Formulated Cysteamine Tranexamic Acid Cream to Treat Melasma
July 2024 | Volume 23 | Issue 7 | Original Article | 529 | Copyright © July 2024
Background: Melasma is a chronic pigmentary disorder. In this study, an innovative cream combining cysteamine and tranexamic acid (TXA) was assessed.Objectiv...
Read MoreSunscreen Practices and Preferences of Skin of Color Patients
June 2024 | Volume 23 | Issue 6 | Original Article | 456 | Copyright © June 2024
Sunscreen is an essential way to protect against photodamage from ultraviolet (UV) radiation. Despite the recognized benefits of sunscreen in preventing skin damage from UV light, its use varies ...
Read MoreDisparities in State Medicaid Coverage of Tretinoin for Pigmentary Disorders Compared to Acne Vulgaris
June 2024 | Volume 23 | Issue 6 | Editorials | e151 | Copyright © June 2024
Background: Melasma and post-inflammatory hyperpigmentation (PIH) are common cosmetic dermatologic conditions that predominantly affect patients with skin phototypes III-VI. Comp...
Read MoreA Practical Algorithm for Integrating Skincare to Improve Patient Outcomes and Satisfaction With Energy-Based Dermatologic Procedures
May 2024 | Volume 23 | Issue 5 | Original Article | 353 | Copyright © May 2024
Media and other results for: "melasma"
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
